The Saudi Mouth — Part 5: The Implant You Might Lose
Saudi Arabia's implant market grows at 9.1% per year. One in five implant patients globally develops peri-implantitis. With Saudi Arabia's diabetes and smoking burden, the risk is higher. Here is what the evidence says about prevention, detection, and what every clinician owes their patients.
Research
Peri-Implantitis, the Saudi Implant Boom, and What Every Clinician Owes Their Patients
Saudi Arabia is in the middle of an implant boom.
The Saudi dental implants market was valued at USD 91.6 million in 2024 and is projected to reach USD 154.8 million by 2030 — growing at a compound annual rate of 9.1%.¹ Patients are seeking implant-based rehabilitation at increasing rates, driven by rising incomes, expanding private dental infrastructure, and a growing cultural expectation that tooth loss is not a permanent condition.
The implant itself is a clinical success story. Osseointegrated titanium implants, when properly selected, placed, and maintained, carry long-term survival rates that rival conventional prosthetic options. The science is mature.
What is less discussed is what happens to the tissues around the implant over time. The disease is called peri-implantitis. And its prevalence figures should be part of every informed consent conversation in every practice placing implants in Saudi Arabia today.
This is Part 5 of The Saudi Mouth.
The Scale of the Problem
Peri-implantitis is a pathological condition affecting the tissues surrounding a dental implant — inflammation in the peri-implant mucosa and progressive loss of supporting bone. Biologically, it is periodontitis around an implant — but more aggressive and less tractable than its natural-tooth equivalent.
The global prevalence figures are sobering.
A 2024 systematic review and meta-analysis commissioned by the American Academy of Periodontology found that nearly half of people with dental implants have peri-implant mucositis, and approximately one in five has peri-implantitis.² At the implant level, peri-implantitis prevalence was 18% (95% CI: 15.8–20.5%).³
Longitudinal data tells a more important story. By ten years, peri-implant mucositis rises to 61% and peri-implantitis to 14%. At twenty years, peri-implantitis is reported in 22% of patients.⁴ This is not a rare complication. It is a predictable consequence of inadequate monitoring — a disease that accumulates in practices that place implants but do not systematically follow them.
In Saudi Arabia specifically, a study at a tertiary dental center found peri-implantitis in 17.59% of patients attending with implants.⁵ Surveys of general dental practitioners in Saudi Arabia revealed significant gaps in peri-implant awareness and diagnostic competence.⁶·⁷
The picture is clear: implant placement in Saudi Arabia is growing rapidly. The infrastructure for long-term peri-implant monitoring is not growing at the same rate.
Why the Saudi Patient Is at Elevated Risk
Peri-implantitis shares its primary risk factors with periodontitis — and the Saudi patient population carries a disproportionate burden of exactly those risks.
Diabetes. Saudi Arabia has a 23.1% adult diabetes prevalence — 5.3 million people. As established in Part 4 of this series, diabetes impairs osseointegration, delays wound healing, and dysregulates the immune response. A 2022 meta-analysis found 77.7% higher odds of implant failure in diabetic patients.⁸ Uncontrolled HbA1c above 8% is associated with significantly worse implant outcomes — making glycemic status a clinical selection criterion, not just a medical history item.
Smoking. A systematic review and meta-analysis found that implants in smokers carry a 140.2% higher risk of failure than in non-smokers.⁹ In the Saudi context — where waterpipe smoking is prevalent and underreported — this risk is likely being systematically undercounted. A patient who answers "no" to "do you smoke?" but uses waterpipe three times a week is carrying a significant implant risk that the clinical record does not reflect.
History of periodontitis. Patients who lost natural teeth partly due to periodontitis have not resolved their susceptibility by switching to implants. This is one of the strongest and most consistent findings in implant research.
Poor oral hygiene. Bacterial plaque accumulation at the implant-abutment interface is the primary initiating factor for peri-implant mucositis. Unresolved mucositis progresses to peri-implantitis in a subset of patients — a preventable cascade, but only if the monitoring system exists to catch it.
The Biology: Why Peri-Implantitis Is More Aggressive
The implant is not a tooth. And the tissue around it is not periodontium.
Natural teeth have a periodontal ligament — a shock-absorbing structure with vascularity, sensory innervation, and regenerative progenitor cells. The connective tissue fibers insert perpendicular into cementum. The junctional epithelium is short and well-supported.
An implant has none of this. The epithelial attachment is longer, less robust, and more permeable. Connective tissue fibers run parallel to the implant surface rather than inserting into it. There is no PDL to buffer inflammatory spread, and peri-implant vascularity is reduced.
Once bacterial challenge overwhelms the mucosal seal, the inflammatory response around an implant spreads to bone faster and with less self-limitation than around a tooth. Bone loss is often circumferential and crater-shaped — and once established, progression tends to be aggressive and nonlinear.
The clinical implication: early intervention at the mucositis stage — before bone is involved — is dramatically more effective than treating established peri-implantitis. Non-surgical debridement resolves mucositis in most cases. Once bone loss has occurred, long-term disease resolution rates following surgical treatment hover around 60%, with approximately 30–40% of cases showing progressive bone loss despite treatment.¹⁰
The window between reversible and difficult-to-treat is the recall appointment.
What Systematic Maintenance Looks Like
A practical framework for every implant patient:
At implant placement — establish the recall schedule. Three months for the first year, then six-monthly if stable, with annual radiographic assessment. Document baseline probing depths, bone levels, and implant stability. This is the reference against which change is measured.
At every recall — probe all peri-implant sites (four to six points), check for bleeding on probing as the earliest sign of mucositis, radiograph if probing depths have increased or bleeding persists, perform professional biofilm removal.
When mucositis is detected — treat immediately. Non-surgical debridement, patient-specific oral hygiene reinforcement, four-to-six week review. Mucositis is reversible. Allow it to progress and it may not be.
When peri-implantitis is detected — refer to a specialist or undertake surgical management. Non-surgical debridement alone has limited efficacy once bone loss has occurred.
Risk stratification — patients with diabetes, smoking history, prior periodontitis, or poor hygiene are high-risk and need quarterly monitoring until stability is demonstrated. They are not candidates for a standard six-month schedule.
The Informed Consent Conversation
The most common complaint from patients who develop peri-implantitis is a simple one: nobody told me this was possible.
An implant consultation that covers surgery, recovery, and aesthetics — but not peri-implant disease risk, maintenance requirements, and the consequences of neglect — is incomplete. Informed consent should include:
- The prevalence of peri-implantitis — approximately 1 in 5 patients over time.
- The patient's specific risk factors — diabetes, smoking, periodontal history.
- The maintenance schedule — framed not as optional follow-up but as a clinical requirement for implant longevity.
- A clear statement: implant placement without long-term maintenance is associated with significantly higher risk of implant loss.
Patients who understand the commitment are more likely to attend. Patients who are not told do not know what they are not doing.
The Role of the General Dental Practitioner
Most implants in Saudi Arabia are placed by specialists. Most of the maintenance will happen in general practices — where patients attend more frequently, where hygiene appointments take place, and where the recall system operates.
Every general dental practitioner who sees implant patients must know:
- How to probe peri-implant sites correctly (0.25N force — same as for natural teeth)
- How to identify bleeding on probing as an early warning sign
- What healthy versus compromised peri-implant radiographic anatomy looks like
- When and to whom to refer
Peri-implantitis is not a specialist disease. Its early detection is a generalist responsibility.
Key Takeaways
- Saudi Arabia's dental implant market grows at 9.1% per year. Globally, 1 in 5 implant patients develops peri-implantitis — a rate that rises with time, risk factors, and absent maintenance.
- Saudi patients carry disproportionate risk: 23.1% diabetes prevalence, high rates of waterpipe smoking, and significant periodontal disease burden — all established peri-implantitis risk factors.
- Smokers face 140.2% higher risk of implant failure. Diabetic patients have 77.7% higher odds of failure. History of periodontitis is one of the strongest predictors of peri-implantitis.
- Peri-implantitis is more aggressive than periodontitis due to the absence of periodontal ligament and distinct tissue architecture. Early intervention at mucositis stage is dramatically more effective.
- Long-term surgical disease resolution is approximately 60%. Prevention through systematic maintenance is the clinical standard of care — not optional follow-up.
- Informed consent must include frank discussion of peri-implantitis risk, patient-specific factors, and the maintenance schedule.
References
- Saudi Arabia Dental Implants Market 2024–2030. https://finance.yahoo.com/news/saudi-arabia-dental-implants-market-081100514.html
- Prevalence, incidence, systemic, behavioral, and patient-related risk factors for peri-implant diseases. AAP/AO Systematic Review. Journal of Periodontology. 2024. PMID: 38591147. https://aap.onlinelibrary.wiley.com/doi/abs/10.1002/JPER.24-0154
- Peri-implantitis prevalence: 25% patients, 18% implants. Science Direct. 2025. https://www.sciencedirect.com/science/article/abs/pii/S0300571225003586
- Longitudinal peri-implantitis data at 10 and 20 years. BSP Research Corner. https://www.bsperio.org.uk/news/research-corner-prevalence-incidence-systemic-behavioral-and-patient-related-risk-factors-and-indicators-for-peri-implant-diseases-an-ao-aap-systematic-review-and-meta-analysis
- Prevalence of peri-implant diseases in Saudi tertiary dental center. Open Dentistry Journal. https://opendentistryjournal.com/VOLUME/17/ELOCATOR/e187421062304070/FULLTEXT/
- Awareness of peri-implantitis among general dental practitioners in Southern Saudi Arabia. PMC. 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC11763348/
- Assessment of knowledge regarding peri-implantitis risk among Saudi dentists. PMC. 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12938006/
- Diabetes and implant failure: 77.7% higher odds. Meta-analysis 2022. https://www.bonitadelrey.com/blog/dental-implant-success-risk-factors-study/
- Smoking and dental implants: 140.2% higher risk of failure. PMC. 2022. PMID: 35093565. https://pmc.ncbi.nlm.nih.gov/articles/PMC8780868/
- Long-term surgical outcomes of peri-implantitis: ~60% disease resolution. Wiley Periodontology. https://onlinelibrary.wiley.com/doi/10.1111/prd.12643
The Saudi Mouth is a SaudiDent original series by Dr. Mahmoud H. Al-Johani. Part 1 — Our Children's Teeth: https://saudident.com/blog/our-childrens-teeth-dental-caries-saudi-arabia Part 2 — The Shisha Session: https://saudident.com/blog/the-saudi-mouth-shisha-waterpipe-oral-health Part 3 — The Lesion You Should Not Miss: https://saudident.com/blog/the-saudi-mouth-oral-cancer-screening Part 4 — The Sixth Complication: https://saudident.com/blog/the-saudi-mouth-diabetes-periodontitis